European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)

Rack, K. A.; van den Berg-de-Ruiter, Eva; Haferlach, Claudia; Beverloo, H. Berna; Costa, Delfina; Espinet Solà, Blanca; Foot, N.; Jeffries, S.; Martin, K.; O’Connor, S.; Schoumans, Jacqueline; Talley, P.; Telford, N.; Stioui, S.; Zemanova, Zuzana; Hastings, Rosalind J.

Home
→
Recerca: articles, congressos, llibres
→
Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
→
Articles (Institut Hospital del Mar d'Investigacions Mèdiques (IMIM))
→
View Item

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)

Document Type: Article

Version: Published version

Date: 2020

This document is associated with a Creative Common license

Copyright © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Name: rack-leu-euro.pdf

Size: 227.1Kb

Format: PDF

View/Open

Citation: Rack KA, van den Berg E, Haferlach C, Beverloo HB, Costa D, Espinet B, et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH). Leukemia. 2020 Aug; 34(8): 2262-4. DOI: 10.1038/s41375-020-0736-x

Permanent link: http://hdl.handle.net/10230/47193